Dawn Pinchasik

Dawn Pinchasik is an accomplished medical professional with extensive experience in clinical development within the biotechnology industry. Currently serving as Vice President of Clinical Development at TScan Therapeutics, Dawn has previously held key positions such as Senior Director of Early Development at ElevateBio and Senior Medical Director of Clinical Development at Rubius Therapeutics. Additional roles include Medical Director at Aileron Therapeutics and Medical Director of Clinical Development at Onyx Pharmaceuticals, an Amgen subsidiary. Dawn Pinchasik holds a Doctor of Medicine (MD) from Drexel University College of Medicine and a Master of Science (M.S.) in Clinical and Translational Research from the University of Cincinnati.